Valiant Laboratories LimitedVALIANTLABNSE
Valiant Laboratories Limited has informed the Exchange about Intimation
As filed · Valiant Laboratories Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
RegulatoryWatchNotablemateriality 61 out of 100
What happened
FactValiant Laboratories Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Phiroze Jeejeebhoy Towers,. For Valiant Laboratories Limited.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
Watch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
Evidence
How CapitSignal classified this
- Reasoning:
- LITIGATION base 56; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%